Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Neurology|October 27, 2018
Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated SyndromeIsmail Koubiyr, Mathilde Deloire, Pierrick Coupé, et al.Neuroimage|February 8, 2018
Deciphering the microstructure of hippocampal subfields with in vivo DTI and NODDI: Applications to experimental multiple sclerosisAmandine Crombe, Vincent Planche, Gerard Raffard, et al.Human Brain Mapping|January 14, 2018
Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA1Vincent Planche, Ismail Koubiyr, José E Romero, et al.NPJ Parkinson'S Disease|April 12, 2025
Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaquesMorgane Darricau, Valentine Kulifaj, Marie-Laure Arotcarena, et al.Stroke|March 4, 2021
Distinct Hippocampal Subfields Atrophy in Older People With Vascular Brain InjuriesGrégoire Pin, Pierrick Coupé, Louis Nadal, et al.Brain : a Journal of Neurology|November 16, 2022
Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primatesMorgane Darricau, Taxiarchis Katsinelos, Flavio Raschella, et al.Journal of Alzheimer'S Disease : JAD|August 20, 2019
A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer's DiseaseBrice Laurens, Vincent Planche, Stéphanie Cubizolle, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2026
Design and baseline findings of the NEODEM prospective cohort on early-onset neurodegenerative dementiaSophie Auriacombe, Emmanuelle Durand, Marion Kret, et al.Communications Biology|November 25, 2025
Alzheimer's Tau seeds-induced pathology enhances hippocampal extracellular diffusionJuan Estaún-Panzano, Anna Lovisotto, Claire Mazzocco, et al.Journal of the Neurological Sciences|November 8, 2017
Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric studyVincent Planche, Xavier Moisset, Remy Morello, et al.Pageof 7